Article Information
History
- February 10, 2020.
Article Versions
- You are currently viewing Version 1 of this article (February 10, 2020 - 11:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matthew A. Cruz1,‡,
- Thomas E. Frederick1,‡,
- Sukrit Singh1,
- Neha Vithani1,
- Maxwell I. Zimmerman1,
- Justin R. Porter1,
- Katelyn E. Moeder1,
- Gaya K. Amarasinghe2 and
- Gregory R. Bowman1,3,*
- 1Department of Biochemistry & Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA
- 2Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
- 3Center for the Science and Engineering of Living Systems, Washington University in St. Louis, St. Louis, MO 63110, USA
- ↵*To whom correspondence should be sent: g.bowman{at}wustl.edu
↵‡ These authors contributed equally to this work
Posted February 10, 2020.
Discovery of a cryptic allosteric site in Ebola’s ‘undruggable’ VP35 protein using simulations and experiments
